Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 5—May 2025
Dispatch
Venezuelan Equine Encephalitis, Peruvian Amazon, 2020
Marta Piche-Ovares, Maria Paquita García Mendoza, Andres Moreira-Soto, Carlo Fischer, Sebastian Brünink, Maribel Dana Figueroa-Romero, Nancy Susy Merino-Sarmiento, Adolfo Ismael Marcelo-Ñique, Edward Málaga-Trillo, Miladi Gatty-Nogueira, César Augusto Cabezas Sanchez, and Jan Felix Drexler
Table 2
Seropositive patients and demographic variables from study of Venezuelan equine encephalitis, Peruvian Amazon, 2020
| Category | VEEV IgG IFA positive, no. (%) | Total no. (%) |
|---|---|---|
| Sex† | ||
| F | 9 (3.9) | 234 (50.4) |
| M |
9 (4.0) |
229 (49.5) |
| Age, y‡ | ||
| <15 | 0 (0.0) | 202 (43.6) |
| 15–29 | 4 (3.3) | 121 (26.1) |
| 30–44 | 7 (9.9) | 71 (15.3) |
| ≥45 | 7 (10.1) | 69 (14.9) |
*Statistical analyses were performed using R version 2024.04.2 (The R Project for Statistical Computing, https://www.r-project.org). VEEV, Venezuelan equine encephalitis virus. †p = 1.0 by Fisher exact test. ‡Compared in 2 age groups: 0–29 and >30 years; p = 0.0001 by Fisher exact test.
Page created: March 18, 2025
Page updated: April 14, 2025
Page reviewed: April 14, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.